IIM
RCUS icon

INTECH Investment Management’s Arcus Biosciences RCUS Stock Holding History

INTECH Investment Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Sell
35,842
-5,224
-13% -$129K 0.01% 986
2026
Q1 		$887K Buy
41,066
+16,249
+65% +$351K 0.01% 1067
2025
Q4 		$591K Buy
24,817
+4,985
+25% +$102K 0.01% 1418
2025
Q3 		$270K Sell
19,832
-14,570
-42% -$151K ﹤0.01% 1892
2025
Q2 		$280K Sell
34,402
-4,908
-12% -$41.9K ﹤0.01% 1904
2025
Q1 		$309K Buy
39,310
+13,155
+50% +$153K ﹤0.01% 1870
2024
Q4 		$389K Buy
26,155
+10,196
+64% +$167K ﹤0.01% 1699
2024
Q3 		$244K Buy
+15,959
New +$252K ﹤0.01% 1630

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

INTECH Investment Management's RCUS Position: Q2 2026 in Review

INTECH Investment Management reduced its Arcus Biosciences (RCUS) stake by 13% in Q2 2026, selling an estimated $129K and leaving 35,842 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #986.

INTECH Investment Management first reported a position in RCUS in Q3 2024 and has held it in 8 quarters since. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • INTECH Investment Management held 35,842 shares of Arcus Biosciences worth $1.11M as of Q2 2026.
  • INTECH Investment Management sold 5,224 Arcus Biosciences shares in Q2 2026, an estimated $129K.
  • Arcus Biosciences made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #986 holding.
  • INTECH Investment Management first reported a position in Arcus Biosciences in Q3 2024 and has held it in 8 quarters since.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.